{1}
##LOC[OK]##
{1}
##LOC[OK]## ##LOC[Cancel]##
{1}
##LOC[OK]## ##LOC[Cancel]##
Return to msk.org
Memorial Sloan Kettering Cancer Center
  • Sign In
  • Live Courses
  • On Demand eLearning
  • Coming Soon
  • Visiting Us
  • About
  • Resources & Policies
  • Help
Close Login
{1}
##LOC[OK]##
{1}
##LOC[OK]## ##LOC[Cancel]##
{1}
##LOC[OK]## ##LOC[Cancel]##

Select a button below to sign in or create an account. If you have previously registered or attended a MSK CME event, please sign in using the username and password created at course registration. MSK employees must use their SSO credentials to sign in. 

Single Sign On (MSK Employees)
Sign in or Create an Account
Enter your email and password to login:

*
*
Login

New to Memorial Sloan Kettering Cancer Center? Create an Account:

Create New Account
Back to Login Provider Forgot Your Password?

Forgot Your Password?







Back to Login
{1}
##LOC[OK]##
{1}
##LOC[OK]## ##LOC[Cancel]##
{1}
##LOC[OK]## ##LOC[Cancel]##
Email is required Invalid: Enter valid email address
First Name is required
Last Name is required
Password is required


Password Requirements

  • Must be between 8 and 16 characters in length
  • Must Contain at least 1 upper case character
  • Must Contain at least 1 lower case character
  • Must contain at least 1 numeric character
  • Must contain at least 1 of the following ! * @ # $ % ^ & + =
Confirm password

Passwords must match
Password must be between 8 and 16 characters and contain the following:
•at least 1 upper case character
•at least 1 lower case character
•at least 1 numerical character
•at least 1 special character

  • -- Select Degree --
  • ACHPN
  • ACNP
  • ACNP-BC
  • AGACNP
  • AGACNP-BC
  • AGCNS
  • AGNP
  • AGNP-BC
  • ANP
  • ANP-BC
  • AS
  • AT
  • AuD
  • BA
  • BAO
  • BCC
  • BCh
  • Bchir
  • BM
  • BS
  • BS, MS
  • BSN
  • BSN, MS
  • BSN, MS, DNP
  • CCC-SLP
  • CCLS
  • CCRN
  • CCRP
  • CEN
  • ChB
  • CIPS
  • CNM
  • CNP
  • CPNP
  • CPNP-AC
  • CRNA
  • CRNP
  • CTTS
  • D(ABMM)
  • DAc
  • DACM
  • DAHM
  • DAOM
  • DDS
  • DDS, MPH
  • DMD
  • DMD, PhD
  • DNB
  • DNP
  • DNP, RN
  • DNSc
  • DO
  • DPM
  • DPM
  • DPT
  • DrPH
  • DSc
  • DVM
  • EdD
  • EdS
  • FAAP
  • FACNM
  • FACOG
  • FACS
  • FASCRS
  • FASN
  • FCCM
  • FCCP
  • FIPP
  • FNP
  • FNP-BC
  • GNP
  • GNP-BC
  • HUC
  • JD
  • LAc
  • LCSW
  • LISW
  • LISW-S
  • LMSW
  • LPCC
  • LPN
  • LSW
  • MA
  • MAc
  • MAcOM
  • MB
  • MB, PhD
  • MBA
  • MBBCh
  • MBBCh BAO
  • MBBCh BAO, PhD
  • MBBCh, MPH
  • MBBCh, PhD
  • MBBS
  • MBBS, MPH
  • MBBS, PhD
  • MBChB
  • MD
  • MD, DSc
  • MD, FCCP
  • MD, FCCP, DAABIP
  • MD, JD
  • MD, MA
  • MD, MAS
  • MD, MBA
  • MD, MHA
  • MD, MPH
  • MD, MPH, MHS
  • MD, MS
  • MD, MS, PhD
  • MD, PhD
  • MD, PhD, MA
  • MD, PhD, MPH
  • MD, PhD, MS
  • MDiv
  • MDS
  • MEd
  • MHS
  • MPA
  • MPH
  • MPhil
  • MS
  • MSc
  • MSc, PhD
  • MSN
  • MSPH
  • NCTTP
  • None
  • NP
  • NP, RN
  • OCN
  • OD
  • Other
  • OTR
  • PA
  • PA-C
  • PCA
  • PharmD
  • PharmD, PhD
  • PhD
  • PhD, MBA, MS
  • PhD, MPH
  • PhD, MPhil
  • PhD, MS
  • PhD, MSc
  • PhD, NP, RN
  • PsyD
  • PT
  • RA
  • RCS
  • RD
  • RDCS
  • RDMS
  • RN
  • RN-BC
  • RPh
  • RRT
  • RT
  • ScD
Degree is required
Please enter your degree:
You must enter a degree

Profession is required




Back to Login
Close Search Site Search: Enter your search terms in the field below to view results.

please enter a term to search
Close Specialties
{1}
##LOC[OK]##
{1}
##LOC[OK]## ##LOC[Cancel]##
{1}
##LOC[OK]## ##LOC[Cancel]##

Fundamentals and Advances in Immunotherapy in the Oncology Patient for the Advanced Practice Provider


Fundamentals and Advances in Immunotherapy in the Oncology Patient  for the Advanced Practice Provider Banner

  • Overview
  • Register
  • Brochure
  • Faculty
  • Schedule
Add to Calendar Fundamentals and Advances in Immunotherapy in the Oncology Patient for the Advanced Practice Provider 1/24/2023 7:50:00 AM 1/24/2023 5:00:00 PM America/New_York For More Details: https://mskcc.cloud-cme.com/course/courseoverview?EID=36239 Description: Immunotherapeutics has changed the treatment modalities available to cancer patients in both solid tumors and hematologic malignancies. Since the breakthrough of ipilimumab, there have been fast-paced and ongoing advancements in the field of immunotherapy, revolutionizing clinical management rapidly. This one-day live virtual course aims to improve cancer patient outcomes by advancing the science,... Online false MM/DD/YYYY


Date & Location
Tuesday, January 24, 2023, 7:50 AM - 5:00 PM, Online

Specialties
Specialties - Allergy and Immunology, Bone Marrow Transplant, Breast Medical Oncology, Cellular Therapeutics, Critical Care, Gastrointestinal Oncology, Genitourinary Oncology, Gynecologic Oncology, Head and Neck Oncology, Hospice and Palliative Medicine, Immunotherapy, Leukemia, Lymphoma, Medical Oncology, Neurology, Neuro-Oncology, Nurse Practitioner, Nursing, Oncology and Hematology, Pharmacology and Medication Management, Physician Assistant, Radiation Oncology, Solid Tumor Oncology

Overview

Immunotherapeutics has changed the treatment modalities available to cancer patients in both solid tumors and hematologic malignancies. Since the breakthrough of ipilimumab, there have been fast-paced and ongoing advancements in the field of immunotherapy, revolutionizing clinical management rapidly.

This one-day live virtual course aims to improve cancer patient outcomes by advancing the science, development, and application of cancer immunology and immunotherapy through fundamental understanding and clinical application. Learners will review fundamental concepts and recent advances in immunotherapy designed to meet the learning needs of advanced practice providers (APPs) and other allied health professionals. Clinical application in solid tumor and hematologic malignancies will be discussed as well as toxicity management, including immune-related adverse events resulting from immune checkpoint inhibition. Experts will discuss the fundamentals of immune checkpoint blockade and CAR T cell therapy, as well as advancements in TIL and BITE therapy, novel combination therapy, and algorithmic management of immune-related adverse events. Toxicity management will be communicated through case study applications and demonstration of common, rare, and severe immune-related adverse events.

Who Should Attend

The target audience for this course includes nurse practitioners, physician assistants, certified registered nurse anesthetists, physicians, and nurses who care for oncology patients. We are pleased to offer complimentary registration for residents, fellows, APP students, and nursing students.

Live Virtual Format

This live virtual program will be delivered using Zoom (zoom.us/download). Detailed access and CME credit instructions will be emailed to attendees prior to the start of the program.

Objectives
  1. Describe the principles surrounding the immunity cycle
  2. Explain fundamental principles of immunotherapeutic agents including immune checkpoint inhibition, CAR T CELL , TIL, and BITE therapies.
  3. Discuss clinical application of immune modulated agents in the oncology population
  4. Discuss the symptoms of Cytokine release Syndrome and clinical management
  5. Recognize and identify common, rare and severe immune related adverse events attributed to immune checkpoint inhibition

Registration

Virtual Registration Fees

  • Physicians (MDs, PhDs, and DOs): $249
  • Advanced Practice Providers: $199
  • Nursing and Other Healthcare Professionals: $149
  • Residents, Fellows, APP Students, and Nursing Students: complimentary; please see below for details
  • Industry Professionals*: $435

*Industry professionals may attend MSK CME activities for their own education. Marketing, sales, and promotion of products and services is strictly prohibited at MSK CME activities. For more information, please visit our Help page.

Discounts/Promotions

  • Residents, Fellows, APP Students, and Nursing Students: please email [email protected] to receive a promotion code for complimentary registration.
  • A registration discount is available for MSK Alumni, and MSK Cancer Alliance to attend a MSK CME course. If you are a member of one of these groups, contact [email protected] for details.
  • Registration is complimentary for all MSK employees; however, you must complete registration through the 'Register' tab above in order to attend this course. If you are registered for this course and are unable to attend, please notify [email protected].

Please note that after your payment has been processed, no further promotional discounts or adjustments will be made to your registration.

Cancellation Policy

If you wish to cancel your participation in this course, you must email [email protected] at least seven (7) days prior to the start of the course, and your refund will be subject to a $25 administrative fee. Cancellations or no-shows within seven (7) days of the course are not eligible for a refund. Please note that if it has been more than 120 days since payment was processed, a W9 form must be submitted in order process your refund and your refund will be issued in the form of a check payment. Refunds are not subject to tax. You may substitute another registrant in your place at any time by contacting [email protected] with the appropriate information.

MSK CME reserves the right to cancel or postpone any course due to unforeseen circumstances. In the unlikely event we must cancel or postpone this course, you will be notified via email from MSK CME ([email protected]). A full refund will be issued for your registration. MSK CME is not responsible for any related costs, charges, or expenses to participants, including fees incurred by airline/travel/lodging agencies.


Accreditation

Memorial Sloan Kettering Cancer Center is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

AMA Credit Designation Statement

Memorial Sloan Kettering Cancer Center designates this live activity for a maximum of 8.00 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.



Keywords: AMA PRA Category 1



MSK Course Director 

Mary Kate Kasler, DNP, RN, ACNP-BC
Advanced Practice Provider

 

MSK Course Co-director

Kerry E. Williams, MSN, RN, ANP-BC, AOCNP
Advanced Practice Provider 

 

MSK Course Physician Sponsor 

Sandra P. D’Angelo, MD
Associate Attending

 

MSK Course Planning Committee

Linda D’Andrea, MSN, RN, PPCNP-BC, CPHON
Advanced Practice Provider Specialist 

Yelena Shames, MSN, RN, ACNP-BC, CNRN
Nurse Leader, Clinical Trials

Kristen Stasi, MSN, RN, OCN
Clinical Trials Nurse

Joanne Wells, MSN, RN, ANP-BC, AOCNP
Advanced Practice Provider 

  

MSK Course Faculty 

Ashley Ames, MSN, RN, AGPCNP-BC
Advanced Practice Provider

Shona Beatty, MS, PA-C
Advanced Practice Provider

Matthew Biniakewitz, BSN, RN, OCN 
Clinical Trials Nurse 

Brianna Cadzin, BSN, RN
Clinical Trials Nurse 

Tara Corso, MS, PA-C 
Advanced Practice Provider 

Jannakie Joseph, NP, AGNP-BC, OCN 
Advanced Practice Provider 

Alexander Lesokhin, MD, PhD 
Associate Attending

Kelly Liotta, BSN, RN 
Clinical Trials Nurse 

Natasha Pinheiro, MSN, RN, AGPCNP-BC, AOCNS 
Advanced Practice Provider 

Mikel Ross, MSN, RN, AGNP-BC, OCN, CBCN 
Advanced Practice Provider 

Alexa Segna, MSN, RN, AGACNP-BC 
Advanced Practice Provider 

Alexander Shoushtari, MD 
Assistant Attending

Dylana Smith, MSN, RN, AGPCNP-BC, HNP 
Advanced Practice Provider

James Smithy MD, MHS
Clinical Fellow

Christine Stefanski, MSN, RN, ANP-BC
Advanced Practice Provider 

Kathryn Walsh, MSN, RN, AGPCNP-BC 
Advanced Practice Provider 



Mitigation of Relevant Financial Relationships


Memorial Sloan Kettering Cancer Center adheres to the ACCME’s Standards for Integrity and Independence in Accredited Continuing Education. Any individuals in a position to control the content of a CE activity, including faculty, planners, reviewers, or others are required to disclose all financial relationships with ineligible companies (commercial interests). All relevant financial relationships have been mitigated prior to the commencement of the activity.



Member Information
Role in activity
Nature of Relationship(s) / Name of Ineligible Company(s)
Kerry E Williams, MSN, RN, ANP-BC, AOCNP
MSK
Activity Co-Director, Faculty
Nothing to disclose
Mary Kate Kasler , DNP
MSK
Activity Director, Conflict of Interest Peer Reviewer, Faculty
Nothing to disclose
Linda D'Andrea, MSN
MSK
Conflict of Interest Peer Reviewer, Faculty
Nothing to disclose
Ashley Ames, FNP-BC, NP
MSK
Faculty
Nothing to disclose
Matthew Biniakiwitz
MSK
Faculty
Nothing to disclose
Briana Cadzin
MSK
Faculty
Nothing to disclose
Tara Corso, PA-C
MSK
Faculty
Nothing to disclose
Jannakie Joseph
MSK
Faculty
Nothing to disclose
Alexander Lesokhin, MD
MSK
Faculty
Advisor-Pfizer, Inc.|Advisor-Arcelyx|Honoraria-Johnson and Johnson (Relationship has ended)|Grant or research support-Bristol-Myers Squibb|Grant or research support-Pfizer, Inc.|Grant or research support-Genentech, Inc.|Grant or research support-Johnson and Johnson|Royalties or Patent Beneficiary-serametrix, inc
Kelly Liotta
MSK
Faculty
Nothing to disclose
Shona Lyne, PA-C
MSKCC
Faculty
Nothing to disclose
Natasha A Pinheiro, NP, MSN
MSK
Faculty
Nothing to disclose
Mikel Ross
MSK
Faculty
Nothing to disclose
Alexa Segna, AGACNP
MSK
Faculty
Nothing to disclose
Alexander Shoushtari, MD
MSK
Faculty
Consulting Fee-Bristol-Myers Squibb|Consulting Fee-Novartis AG|Consulting Fee-Immunocore|Grant or research support-Polaris (Relationship has ended)|Grant or research support-Pfizer, Inc.|Grant or research support-Foghorn Therapeutics|Grant or research support-Checkmate Pharmaceuticals|Grant or research support-Targovax ASA|Grant or research support-Linnaeus Therapeutics|Grant or research support-Iovance Biotherapeutics
Dylana Smith, MS, AGPCNP-BC, HNP
MSK
Faculty
Nothing to disclose
James Smithy, MD
MSK
Usa
Faculty
Nothing to disclose
Christine Stefanski, NP
MSK
Faculty
Nothing to disclose
Kathryn Walsh, AGACNP
MSK
Faculty
Nothing to disclose
Sandra P. D'Angelo, MD
MSK
Faculty, Physician Faculty Sponsor
Consulting Fee-EMD Serono, Amgen, Nektar, Immune Design, GlaxoSmithKline, Incyte, Merck, Adaptimmune, Immunocore, Pfizer, Servier, Rain Therapeutics, GI Innovations, Aadi Bioscience|Other: Travel, Accommodations, Expenses-Adaptimmune, EMD Serono, Nektar|Advisor-GlaxoSmithKline, Nektar, Adaptimmune, Merck
Yelena Shames, ANP
MSK
Faculty, Planner
Nothing to disclose
Kristen Stasi
MSK
Faculty, Planner
Nothing to disclose
Joanne Wells, ANP, AOCNP
MSK
Faculty, Planner
Nothing to disclose

Tuesday, January 24, 2023

SYLLABUS DISCLAIMER
7:50AM - 8:00AM

Please note only the presentations from faculty that have given their consent will be available below:


Relevant Financial Relationships
8:00AM - 8:10AM

To view faculty disclosures, please visit the course website (mskcc.org/immunoAPPcourse) and select the Faculty tab. All relevant financial relationships have been mitigated prior to the commencement of the activity.


Mechanism of Action of Checkpoint Blockade PD1, PDL1, CTLA-4
8:15AM - 8:45AM
James Smithy, MD
Discussion of Novel Checkpoint Inhibitors and Combination Therapy
8:45AM - 9:15AM
Alexander Shoushtari, MD
Algorithmic Management and Grading of Immune-Related Adverse Events
9:15AM - 9:30AM
Alexander Shoushtari, MD
Fundamentals of Immune Checkpoint Blockade Panel Discussion
9:30AM - 9:45AM
Kerry E Williams, MSN, RN, ANP-BC, AOCNP (Moderator)
Clnical Updates in Non-Small Cell Lung Cancer
9:55AM - 10:15AM
Joanne Wells, ANP, AOCNP
Clinical Updates in Sarcoma and Merkel Cell Carcinoma
10:15AM - 10:35AM
Matthew Biniakiwitz
Clinical Updates in Rectal Squamous Cell Carcinoma
10:35AM - 10:55AM
Natasha A Pinheiro, NP, MSN
Clinical Updates in Metastatic Breast Cancer
10:55AM - 11:15AM
Mikel Ross
Alexa Segna, AGACNP
Clinical Updates in Head and Neck Squamous Cell Carcinoma
11:15AM - 11:35AM
Christine Stefanski, NP
Clinical Application of Immune Checkpoint Inhibitors in Solid Tumor Malignancy Panel Discussion
11:35AM - 11:55AM
Mary Kate Kasler , DNP (Moderator)
Clinical Updates in Lymphoma
12:05PM - 12:25PM
Ashley Ames, FNP-BC, NP
Clinical Updates in Myeloma
12:25PM - 12:45PM
Alexander Lesokhin, MD
Clinical Application of Immune Therapy in Hematologic Malignancy Panel Discussion
12:45PM - 1:00PM
Kristen Stasi (Moderator)
Overview of Chimeric Antigen Receptor (CAR) T Cell Immunotherapy
1:35PM - 1:55PM
Briana Cadzin
Mechanism of Action and Clinical Applications of Tumor Infiltrating Lymphocytic (TIL) Therapy
1:55PM - 2:15PM
Jannakie Joseph
BITE and CAR T cell therapy in the Acute Leukemia Patient: A Case Study Approach
2:15PM - 2:45PM
Shona Lyne, PA-C
Kathryn Walsh, AGACNP
Cytokine Release Syndrome
2:45PM - 3:05PM
Kelly Liotta
Fundamentals of T Cell Therapy Panel Discussion
3:05PM - 3:25PM
Yelena Shames, ANP (Moderator)
Gastrointestinal Immune-Related Adverse Event: Colitis
3:35PM - 3:55PM
Tara Corso, PA-C
Neurological Immune-Related Adverse Event: Myasthenia Gravis
3:55PM - 4:15PM
Yelena Shames, ANP
Cardiac Immune-Related Adverse Event: Myocarditis
4:15PM - 4:35PM
Dylana Smith, MS, AGPCNP-BC, HNP
Clinical Considerations for Immune Checkpoint Toxicities Panel Discussion
4:35PM - 4:55PM
Joanne Wells, ANP, AOCNP (Moderator)


CME Courses

Live Courses
On Demand eLearning
Coming Soon

Resources & Policies

CME Program Terms of Use
Registration Discounts
Cancellation Policy
Industry Professionals

Attendee & Faculty Information

My CME / Attendee Resources
Claim RSS Credit (MSK Staff)
Faculty Disclosure Form
Faculty Tasks Page

Connect

Locations & Visitor Info
Help / Contact Us
Subscribe to CME Announcements




MSK CME

Memorial Sloan Kettering Cancer Center is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

©2025 Memorial Sloan Kettering Cancer Center